Tech Hub | August 25, 2021
The sequencing, analysis, and interpretation of the human genome, which leads to therapeutic, diagnostic, and wellness applications. Not part of subscription
News Commentary | September 17, 2021
NHS will use GRAIL's Galleri test in this study, which aims to recruit 140,000 volunteers in eight areas of England. Besides being touted as the world's first and largest clinical trial of its kind, the more important significance of this study is that it is being spearheaded by one of the largest ... Not part of subscription
News Commentary | November 15, 2021
COVID‑19 home tests are becoming the norm in many countries. It is a core technology in the COVID‑19 toolkit for easing restrictions and reopening economies. Hence, when Ellume recalled its COVID‑19 home tests due to high false‑positive rates, there were concerns about other tests on the market. The... Not part of subscription
by Danielle Bradnan
The study is not only timely but also groundbreaking in that it is device-agnostic and driving a pool of data notably not siloed by device manufacturers. The study will run for two years, which roughly aligns with projections for vaccine availability for COVID-19, and will be important not only for early front-line detection leading up to a vaccine being available to the public but also for population health management after the current crisis has passed. Clients should be looking to partner with companies running similar studies for digital biomarkers, such as Oura, to play a key role in this evolving global situation and, just as importantly, to keep a relevant place in the healthcare conversation after it is over.
For the original news article, click here .